FOLFOXIRI Plus Bevacizumab With or Without Atezolizumab as 1st Line Treatment of pMMR and IS IC-High Metastatic Colorectal Cancer Patients.

Abroad (travel likely)RecruitingPHASE3

Conditions

Colorectal Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
Study leads
  • Carlotta Antoniotti, MD, PhD

    Principal Investigator

    Department of Translational Research and New Technologies in Medicine and Surgery - University of Pisa